Heart:70岁以上未服用他汀类药物的男性总胆固醇过低与严重不良心血管事件相关

2019-10-14 xing.T MedSci原创

由此可见,在没有IHD且未接受他汀类药物治疗的男性中,低TC与MACE的发生风险增加有关。

胆固醇(TC)含量低与老年人群的不良结局有关,这种现象是否独立于他汀类药物的使用尚不清楚。近日,心脏病领域权威杂志Heart上发表了一篇研究文章,研究人员对≥70岁无缺血性心脏病(IHD)的男性进行了一项前瞻性研究,探究了低TC水平与长期重大心血管不良事件(MACE)之间的关系,以及这是否受到他汀类药物的影响。

男性健康与老龄化项目(CHAMP)队列是一项对年龄≥70岁的社区居住的男性进行的前瞻性队列研究。TC和长期MACE之间的关系使用校正了合并症的Cox回归模型进行了分析,并通过他汀类药物的使用进行了分层。 

该研究队列纳入了1289名男性(平均(±SD)年龄为77.0±5.5岁,平均随访时间6.4±2.7年),TC水平降低与合并症负担、虚弱和MACE增加相关(线性趋势p<0.001)。在未接受他汀类药物治疗的男性中(n=731),TC的每降低1mmol/L与MACE(HR为1.27,95%CI为1.10至1.45,p=0.001)和死亡率(HR为1.22,95%CI为1.03-1.44,p=0.02)相关。相比之下,接受他汀类药物治疗的男性低TC(n=558)与MACE(HR为0.91,95%CI为0.74至1.11)或死亡率(HR为0.86,95%CI为0.68至1.09)无关。

由此可见,在没有IHD且未接受他汀类药物治疗的男性中,低TC与MACE的发生风险增加有关。 

原始出处:

Sonali Rukshana Gnanenthiran.et al.Low total cholesterol is associated with increased major adverse cardiovascular events in men aged ≥70 years not taking statins.heart.2019.http://dx.doi.org/10.1136/heartjnl-2019-315449

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1643653, encodeId=d3971643653ab, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Tue Oct 29 14:18:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655289, encodeId=3ec2165528912, content=<a href='/topic/show?id=966552e7237' target=_blank style='color:#2F92EE;'>#总胆固醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52772, encryptionId=966552e7237, topicName=总胆固醇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741e24715588, createdName=ycmayy, createdTime=Tue Sep 15 03:18:00 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044563, encodeId=0e3b2044563d8, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25344, encryptionId=644725344b1, topicName=他汀类药)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Jan 17 02:18:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357286, encodeId=6363135e28690, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Oct 16 11:18:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563157, encodeId=6967156315e78, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Oct 16 11:18:00 CST 2019, time=2019-10-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1643653, encodeId=d3971643653ab, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Tue Oct 29 14:18:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655289, encodeId=3ec2165528912, content=<a href='/topic/show?id=966552e7237' target=_blank style='color:#2F92EE;'>#总胆固醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52772, encryptionId=966552e7237, topicName=总胆固醇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741e24715588, createdName=ycmayy, createdTime=Tue Sep 15 03:18:00 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044563, encodeId=0e3b2044563d8, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25344, encryptionId=644725344b1, topicName=他汀类药)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Jan 17 02:18:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357286, encodeId=6363135e28690, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Oct 16 11:18:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563157, encodeId=6967156315e78, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Oct 16 11:18:00 CST 2019, time=2019-10-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1643653, encodeId=d3971643653ab, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Tue Oct 29 14:18:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655289, encodeId=3ec2165528912, content=<a href='/topic/show?id=966552e7237' target=_blank style='color:#2F92EE;'>#总胆固醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52772, encryptionId=966552e7237, topicName=总胆固醇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741e24715588, createdName=ycmayy, createdTime=Tue Sep 15 03:18:00 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044563, encodeId=0e3b2044563d8, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25344, encryptionId=644725344b1, topicName=他汀类药)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Jan 17 02:18:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357286, encodeId=6363135e28690, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Oct 16 11:18:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563157, encodeId=6967156315e78, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Oct 16 11:18:00 CST 2019, time=2019-10-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1643653, encodeId=d3971643653ab, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Tue Oct 29 14:18:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655289, encodeId=3ec2165528912, content=<a href='/topic/show?id=966552e7237' target=_blank style='color:#2F92EE;'>#总胆固醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52772, encryptionId=966552e7237, topicName=总胆固醇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741e24715588, createdName=ycmayy, createdTime=Tue Sep 15 03:18:00 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044563, encodeId=0e3b2044563d8, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25344, encryptionId=644725344b1, topicName=他汀类药)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Jan 17 02:18:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357286, encodeId=6363135e28690, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Oct 16 11:18:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563157, encodeId=6967156315e78, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Oct 16 11:18:00 CST 2019, time=2019-10-16, status=1, ipAttribution=)]
    2019-10-16 zhaojie88
  5. [GetPortalCommentsPageByObjectIdResponse(id=1643653, encodeId=d3971643653ab, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Tue Oct 29 14:18:00 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655289, encodeId=3ec2165528912, content=<a href='/topic/show?id=966552e7237' target=_blank style='color:#2F92EE;'>#总胆固醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52772, encryptionId=966552e7237, topicName=总胆固醇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741e24715588, createdName=ycmayy, createdTime=Tue Sep 15 03:18:00 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044563, encodeId=0e3b2044563d8, content=<a href='/topic/show?id=644725344b1' target=_blank style='color:#2F92EE;'>#他汀类药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25344, encryptionId=644725344b1, topicName=他汀类药)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Jan 17 02:18:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357286, encodeId=6363135e28690, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Oct 16 11:18:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563157, encodeId=6967156315e78, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Oct 16 11:18:00 CST 2019, time=2019-10-16, status=1, ipAttribution=)]
    2019-10-16 slcumt

相关资讯

GUT:他汀类药物与结肠镜后结肠直肠癌

研究认为,他汀类药物可降低结肠镜后结肠直肠癌风险,特别是近端癌

JAHA:终末期肾病前他汀类药物治疗与之后结局的关系

由此可见,在非透析依赖性慢性肾病的退伍军人中,转变为终末期肾病之前的1年内使用他汀类药物治疗与有利的早期终末期肾病结局相关。

JAHA:经导管主动脉瓣膜置换术后他汀类药物使用与死亡率的关系

由此可见,在TAVR患者的观察性倾向性匹配分析中,与未使用他汀类药物相比,他汀类药物使用与心血管和非心血管死亡率降低相关。鉴于他汀类药物明显保护作用的早期出现,尽管存在倾向匹配方法,但这种结果可能由多效性或残余混杂因素所致。

JCEM:他汀类药物使用与性激素的关系

由此可见,他汀类药物使用者的SHBG和DHEA水平降低。鉴于他汀类药物治疗的使用日益增加,这一相关性值得引起关注。

Diabetes Care:美国成年糖尿病患者服用他汀类药物后高甘油三酸酯血症和估计的动脉粥样硬化性心血管疾病风险

由此可见,五分之一(约550万)的美国糖尿病成人会发生HTG,包括接受他汀类药物治疗和LDL-C控制良好的糖尿病患者。超过四分之三的HTG的成年人有中等或较高的10年ASCVD风险。需要做出更大的努力来促进生活方式和药物手段以解决HTG。

JAHA:胸部、头颈部放射治疗后癌症患者他汀类药物使用与血管事件风险

由此可见,放射治疗后使用他汀类药物与卒中显著减少有关,并且趋向于显著减少心血管和脑血管事件。